Year To Quarter End Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7330327

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
119,532,000,000 JPY
105,157,000,000 JPY
JPY
113,270,000,000 JPY
Cost of sales
68,124,000,000 JPY
56,796,000,000 JPY
JPY
63,102,000,000 JPY
Gross profit (loss)
51,408,000,000 JPY
48,361,000,000 JPY
5,853,000,000 JPY
50,167,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
2,381,000,000 JPY
2,211,000,000 JPY
Selling, general and administrative expenses
45,394,000,000 JPY
41,682,000,000 JPY
2,793,000,000 JPY
45,043,000,000 JPY
Operating profit (loss)
6,013,000,000 JPY
6,679,000,000 JPY
3,059,000,000 JPY
5,123,000,000 JPY
Non-operating income
Interest income
41,000,000 JPY
76,000,000 JPY
59,000,000 JPY
19,000,000 JPY
Dividend income
459,000,000 JPY
578,000,000 JPY
JPY
446,000,000 JPY
Non-operating income
735,000,000 JPY
804,000,000 JPY
93,000,000 JPY
799,000,000 JPY
Non-operating expenses
Interest expenses
66,000,000 JPY
56,000,000 JPY
177,000,000 JPY
66,000,000 JPY
Share of loss of entities accounted for using equity method
12,000,000 JPY
0 JPY
Non-operating expenses
146,000,000 JPY
66,000,000 JPY
177,000,000 JPY
94,000,000 JPY
Ordinary profit (loss)
6,602,000,000 JPY
7,417,000,000 JPY
2,975,000,000 JPY
5,827,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
0 JPY
JPY
10,000,000 JPY
Extraordinary income
1,404,000,000 JPY
48,537,000,000 JPY
JPY
1,979,000,000 JPY
Extraordinary losses
Impairment losses
JPY
257,000,000 JPY
Loss on disaster
27,000,000 JPY
JPY
Extraordinary losses
987,000,000 JPY
938,000,000 JPY
0 JPY
900,000,000 JPY
Profit (loss) before income taxes
7,019,000,000 JPY
55,016,000,000 JPY
2,974,000,000 JPY
6,906,000,000 JPY
Income taxes - current
1,897,000,000 JPY
2,046,000,000 JPY
-25,000,000 JPY
2,462,000,000 JPY
Income taxes - deferred
-200,000,000 JPY
-25,000,000 JPY
-5,000,000 JPY
-279,000,000 JPY
Income taxes
1,696,000,000 JPY
2,020,000,000 JPY
-31,000,000 JPY
2,182,000,000 JPY
Profit (loss)
52,995,000,000 JPY
5,322,000,000 JPY
52,995,000,000 JPY
52,995,000,000 JPY
52,995,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
4,723,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
5,322,000,000 JPY
5,322,000,000 JPY
5,322,000,000 JPY
4,723,000,000 JPY
4,723,000,000 JPY
4,723,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
201,000,000 JPY
-578,000,000 JPY
Foreign currency translation adjustment
-340,000,000 JPY
229,000,000 JPY
Remeasurements of defined benefit plans, net of tax
2,736,000,000 JPY
-394,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
30,000,000 JPY
5,000,000 JPY
Other comprehensive income
2,627,000,000 JPY
-737,000,000 JPY
Comprehensive income
7,949,000,000 JPY
3,986,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
7,949,000,000 JPY
3,986,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.